Evaluation of the Postprandial-Hyperglycemia-Suppressing Effects and Safety of Short-Term Intake of Mulberry Leaf and Water Chestnut Tea: A Randomized Double-Blind Placebo-Controlled Crossover Trial
Nutrients · 2025
DOI: 10.3390/nu17142308 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Yuya Shinkawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science, Graduate School of Medical Science, Saga University, Saga 849-8501, Japan. Hauptthemen laut MEDLINE: Hyperglycemia, Morus, Plant Extracts, Postprandial Period. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kanzaki City and the "Regional Revitalization Future Project" at Saga University and the JST CREST, Kanzaki City and the “Regional Revitalization Future Project” at Saga University, JST CREST.
Abstract (Originalsprache)
Background/Objectives: Postprandial hyperglycemia is a risk factor for diabetes and cardiovascular diseases, even in healthy individuals. Kanzaki mulberry leaf and water chestnut tea (MW tea), a blend of mulberry (Morus alba) leaves and water chestnut (Trapa japonica) leaves and husks, is rich in polyphenols and 1-deoxynojirimycin (DNJ) and may suppress postprandial glucose spikes, but evidence regarding its short-term daily intake is limited. This study aimed to evaluate the postprandial glycemic response and safety of two-week MW tea consumption using continuous glucose monitoring (CGM).
Methods
We conducted a randomized, double-blind, placebo-controlled, two-period crossover trial involving 31 participants. Each intervention period lasted two weeks, separated by a one-week washout. Participants consumed either MW tea or a placebo before meals. Interstitial glucose levels were measured every 15 min using CGM. Postprandial glucose responses were recorded every 15 min for 180 min after a standardized meal on the first day of each period. The primary outcome was the coefficient of variation (CV) in glucose levels, calculated using data from the central 10 days of each intervention period. Safety was assessed using CGM-derived hypoglycemia metrics and blood test results.
Results
The CV of glucose levels during the MW tea period was significantly lower than during the placebo period (mean difference: 0.02, p = 0.0006). A significant reduction in 1 h postprandial glucose area under the curve was also observed. No significant differences were found in hypoglycemia occurrence, liver/renal/inflammatory markers, or self-reported adverse symptoms. Notably, 1,5-anhydroglucitol (1,5-AG) levels significantly increased during MW tea intake, suggesting improved glycemic control.
Conclusions
Short-term consumption of Kanzaki MW tea effectively suppressed postprandial glucose variability without safety concerns. These findings support MW tea as a promising natural supplement for glycemic management and the prevention of diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Science, Graduate School of Medical Science, Saga University, Saga 849-8501, Japan.
- Department of Health and Nutrition Sciences, Nishikyushu University, Saga 842-8585, Japan.
- Department of Preventive Medicine, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
- Department of Social and Environmental Medicine, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
- Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
ORCID-Profile: Yuichiro Nishida, Mikiko Tokiya, Akiko Matsumoto, Megumi Hara
Förderung
- Kanzaki City and the "Regional Revitalization Future Project" at Saga University and the JST CREST
- Kanzaki City and the “Regional Revitalization Future Project” at Saga University
- JST CREST
Zitieren
APA
Shinkawa, Y., Yasuda, M., Nishida, Y., Tokiya, M., Takagi, Y., Matsumoto, A., Kawaguchi, A., & Hara, M. (2025). Evaluation of the Postprandial-Hyperglycemia-Suppressing Effects and Safety of Short-Term Intake of Mulberry Leaf and Water Chestnut Tea: A Randomized Double-Blind Placebo-Controlled Crossover Trial. Nutrients. https://doi.org/10.3390/nu17142308
Vancouver
Shinkawa Y, Yasuda M, Nishida Y, Tokiya M, Takagi Y, Matsumoto A, et al. Evaluation of the Postprandial-Hyperglycemia-Suppressing Effects and Safety of Short-Term Intake of Mulberry Leaf and Water Chestnut Tea: A Randomized Double-Blind Placebo-Controlled Crossover Trial. Nutrients. 2025. doi:10.3390/nu17142308
BibTeX
@article{Shinkawa2025,
author = {Shinkawa, Yuya and Yasuda, Midori and Nishida, Yuichiro and Tokiya, Mikiko and Takagi, Yusuke and Matsumoto, Akiko and Kawaguchi, Atsushi and Hara, Megumi},
title = {Evaluation of the Postprandial-Hyperglycemia-Suppressing Effects and Safety of Short-Term Intake of Mulberry Leaf and Water Chestnut Tea: A Randomized Double-Blind Placebo-Controlled Crossover Trial},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17142308}
}
EUVIMED